FDA's Cancer-Drug Reviewers Often Join Industry Later: Study

TUESDAY, Sept. 27, 2016 — Among federal employees who review new cancer-drug applications for the U.S. Food and Drug Administration, about half who leave to work elsewhere end up working for the industry they once regulated.
That’s what researchers…
Source: Topamax